Orion Stock - operational focus on specialty pharma and animal health
17.06.2026 - 19:07:28 | ad-hoc-news.de
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 19:05 CET. Details in the imprint.
Orion (FI0009014377) is a Finnish pharmaceutical company with a focus on prescription drugs, self-care products and animal health solutions listed in Helsinki. On this Wednesday the spotlight is on its operating structure and strategic positioning across core therapeutic areas.
Background and price data on Orion stock
Investors can follow all regulatory filings, financial reports and key figures on Orion through the company’s investor relations pages and dedicated stock overview.
How Orion organizes its operations
Orion’s operations are structured into two main business segments: Pharmaceuticals and the Fermion active pharmaceutical ingredient unit. Within Pharmaceuticals, the company reports commercial businesses such as Branded Products, Generic Products, Consumer Health and Animal Health.
The group’s prescription portfolio covers central nervous system disorders, oncology and respiratory diseases among other areas. Alongside human medicines, Orion develops and markets veterinary drugs and products through its Animal Health business, which serves both production animals and pets.
Wednesday focus on strategy and operations
Strategically, Orion highlights its ambition to grow in specialty care, particularly in oncology and critical care, while maintaining a strong position in generic and over-the-counter medicines. Management also emphasizes partnerships and licensing deals as a way to access innovative molecules and expand its pipeline.
The Fermion unit manufactures active pharmaceutical ingredients for Orion’s own products and external customers, supporting vertical integration and cost control. This combination of proprietary brands, generics, self-care lines and API production creates several operating levers across the value chain.
How the company makes money
Orion generates revenue primarily from the sale of proprietary prescription drugs, generic medicines and self-care products, complemented by animal health and API sales. Key brands and molecules span neurologic conditions, cancer therapies and inhaled respiratory treatments across Europe and selected global markets.
Where the stock trades today
Orion shares trade on Nasdaq Helsinki at EUR 32.10 as of 06/17/2026, 18:50 CET.
Key facts on Orion stock
- Company: Orion Oyj
- ISIN: FI0009014377
- WKN: 862401
- Ticker: ORNAV
- Venue: Nasdaq Helsinki
- Price (as of 06/17/2026, 18:50 CET): 32.10 EUR
- Market cap: 5,090,000,000 EUR (as of 06/17/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: OMX Helsinki 25
- Next earnings date: 07/18/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
